A new study presented at this year’s EULAR conference found a doubled risk of pre-malignant cervical changes, and potentially also an increased risk of cervical cancer, among women with systemic lupus erythematosus (SLE) compared to the general female population. The highest risks were found in women with lupus who were treated with immunosuppressant drugs. These findings highlight the importance of regular cervical screening in all women with SLE.

Click here for more.